About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1109 record(s)
Req # A-2019-001113
Copies of similar reports to the investigation of environmental Perfluorinated alkyl substance (PFAS) contamination report requested under file A-2019-000924.Organization: Health Canada
November 2020
Req # A-2019-001502
Copy of the statistics/data that AIDS Outreach Community Harm Reduction Education & Support Society (ARCHES) would have had to report to Health Canada as part of the renewal of their latest S.56 exemption.Organization: Health Canada
November 2020
Req # A-2020-000198
Adverse Reaction Report (AER). Report number: E2B_02978822.Organization: Health Canada
November 2020
Req # A-2019-001760
The adverse event reports regarding the drugs used to treat Attention Deficit Hyperactivity Disorder (ADHD) and the risks of suicidal thoughts and behaviour in certain individuals. Since 2015.Organization: Health Canada
November 2020
Req # A-2020-000298
All Adverse Drug Reactions (ADRs) for Ranitidine products listed in the Health Canada public advisories dated September 13, 2019 and September 25, 2019. Original forms/reports only from September 1, 2014 to September 20, 2019.Organization: Health Canada
November 2020
Req # A-2020-000569
Reviewer reports and/or correspondence between Health Canada and the drug company (outside of the drug submission binders), which relate to the original submission for Pentacel in 1997.Organization: Health Canada
November 2020
Req # A-2020-000579
All electronic documents relating to tobacco product seizures and warning letters pertaining to STLTH as referred to by Health Canada in its response to the Inquiry of Ministry of Mr. Davies on January 23, 2020.Organization: Health Canada
November 2020
Req # A-2020-000649
For the Abbreviated New Drug Submission underlying the generic submission containing the medicinal ingredient “Eltrombopag olamine” included on Health Canada’s Generic Submissions Under Review List, provide the proposed Certified Product Information Document - Chemical Entities.Organization: Health Canada
November 2020
Req # A-2020-000466
Adverse Reaction Report (AER) for botulinum toxin. Report number: E2B_03008417.Organization: Health Canada
November 2020
Req # A-2020-000650
For the Abbreviated New Drug Submission underlying the generic submission containing the medicinal ingredient “Eltrombopag olamine” included on Health Canada’s Generic Submissions Under Review List, provide the “Drug Substance - Nomenclature” .Organization: Health Canada
November 2020